Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding
Pharmacy Times
JULY 18, 2025
The definition of "essentially a copy" is pivotal, influencing compounding practices and legal interpretations. Rumore, PharmD, Esq, MS, LLM, FAPhA Key Takeaways The removal of tirzepatide and semaglutide from the FDA's shortage list impacts 503A compounders, requiring adherence to complex legal and regulatory frameworks.
Let's personalize your content